IL6 and serum lipopolysaccharide activity: Specifically, Pro9-3 effectively reduced the serum levels of the inflammatory cytokines TNF-α and IL-6 by 54.5% and 39.4%, respectively, in the LPS-induced endotoxemia mouse model (Fig. 4B).